| 000 | 02489nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 85175 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040459.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 160210s2016 gw | s |||| 0|eng d | ||
| 020 | _a9783319262062 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC523 _b2016 EB |
|
| 100 | 1 |
_aKudo, Takashi _941937 |
|
| 245 | 1 | 0 |
_aPractical Pharmacology for Alzheimer�s Disease _cby Takashi Kudo, Kenneth L Davis, Rafael Blesa Gonzalez, David George Wilkinson |
| 250 | _a1st ed. | ||
| 260 |
_aCham _bSpringer International Publishing _c2016 |
||
| 300 | _a1 recurso en línea (VIII, 141 p.) 27 il., 9 il. col. | ||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 520 | _aThe wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer�s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer�s disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia. | ||
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aAlzheimer, Enfermedad de _9144620 _0comprobar BNE19912923051 _2embne |
|
| 700 | 1 |
_aDavis, Kenneth L., _d1947- _0Local _9674698 |
|
| 700 | 1 |
_aBlesa Gonzalez, Rafael _9152 _0comprobar BNE19931539143 |
|
| 700 | 1 |
_aWilkinson, David George _997923 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-26206-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _aii9783319262062 | ||
| 907 |
_a.b12944531 _b10-10-17 _c21-11-16 |
||
| 988 | _aSpringer_Medicine_2016 | ||
| 998 |
_am _a_alco _a_vill _b10-03-17 _cm _dz _ef _feng _ggw _h0 |
||
| 945 |
_aRC523 .K836 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11588561 _z06-04-17 |
||
| 999 |
_c85175 _d85175 _x1 |
||